Location: Palo Alto, CA
CIK: 0001664974 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $67.98M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EVLV | Evolv Technologies Holdings, Inc. | 5,000,000 | $37.75M | 55.5% | $5.61 | +30.1% | COM CL A | 30049H102 |
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $28.99M | 42.6% | $18.82 | -72.1% | CL A | 75629V104 |
| — | Mind Medicine (MindMed) Inc. | 100,350 | $1.183M | 1.7% | $3.17 | — | COM NEW | 60255C885 |
| ROIV | Roivant Sciences Ltd. | 3,875 | $58,629 | 0.1% | $5.56 | +122.5% | SHS | G76279101 |